EGFR and pancreatic neoplasm: Our study demonstrated that CuB not only decreased pSTAT3 protein levels, but also inhibited endogenous EGFR, pEGFR, pAkt (T308), pAkt (S473) and pS6 levels in a dose-dependent manner in pancreatic cancer cells.